About
Efferon develops and manufactures a CE-marked multimodal extracorporeal blood purification device designed to treat sepsis, septic shock, cytokine storm, and endotoxemia, with clinical validation and use in both adult and pediatric patients worldwide.
Explore Efferon's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.